We hypothesized that higher serum IGF-I would be associated with larger brain white matter volumes and better neuropsychological test performance in SCI/MCI, whereas in AD, such associations would not be seen due to resistance to the effects of IGF-I in the brain white matter. Here, IGF1 is linked to Alzheimer disease.